3rd gen closed filling system wins gold Good Design Award

Invetech’s 3rd Generation Closed Filling System for cell and gene therapy has received a prestigious Good Design Award Gold Accolade in the Product Design, Medical and Scientific category in recognition for outstanding design and innovation.

The 3rd Generation Closed Filling System is a Good Manufacturing Practice (GMP)-based system for the commercial production of cell-based therapeutic products. The system can be managed by a single operator utilizing closed disposables to enable low-grade cleanroom operations, and can be easily configured for various products, including master and working cell bank, cell product, viral vector and media packaging. It has a standardized system architecture that is highly configurable to meet specific manufacturing needs including throughput, batch size, fill volume, contact materials, process control and data interfaces, and temperature management.

In presenting the award to Invetech’s 3rd Generation Closed Filling System, the Good Design Awards Jury commented: “An innovative approach to conducting cell therapy operations. The design draws on reconfigurable structures and enables single operator use – a significant improvement on previous approaches. The scalability of the Invetech solution will have an impact on workflow in important areas of research. It is refreshing to see good design at scale being developed in Australia and an advanced manufacturing product so elegantly resolved.”

Dr. Brandon Gien, CEO of Good Design Australia said: “Receiving a Good Design Award is a significant achievement given the very high calibre and record number of entries received in 2020.”

Good Design Award trophy

David Kneen, Invetech’s Vice President, Cell Therapy said, “We are thrilled to be recognized by the Good Design Award judging panel and to have received this prestigious award for design and innovation. “

“Our 3rd Generation Filling System, in parallel with Invetech’s broad portfolio of cell and gene therapy manufacturing platforms, allows therapy manufacturers to safely scale their operations, ultimately delivering more life-changing therapies to more patients in need.”

“The Filling System specifically addresses three fundamental manufacturing challenges facing today’s cell and gene therapy industry – process variability, reliance on skilled operators and the prohibitive expense of manual processes. The equivalent manual fill process previously took 4-6 operators 24 hours, and despite all care, still saw high product variability. Utilizing our system, a single operator in a single shift can complete the same process, delivering higher yield and avoiding the difficulty and expense of operating in a high-grade cleanroom.”

The 2020 Good Design Awards attracted a record number of submissions with an astonishing 835 design projects evaluated in this year’s international design awards.

“There’s no doubt it has been a really tough year for everyone so it’s nice to be able to share some good news for a change. The projects represented in this year’s Good Design Awards shine a positive light on our creative and innovative capacity as human beings. These inspirational winning projects give me hope and optimism that our design community will continue to innovate, no matter how challenging the world around us is,” said Dr. Gien.

Find out more about Invetech’s 3rd Generation Filling System and Formulation and Filling Systems.

About Invetech

Invetech delivers optimal client-focused outcomes by solving commercial, usability and manufacturing challenges for commercial-scale cell and gene therapy applications and clinical lab and point of care diagnostics. Since 2003, Invetech’s Cell Therapy group has provided Assured Pathways™ to the commercial manufacturing of cell, gene and tissue therapies, including peripheral and precursor materials such as viral vector and media. Invetech configures manufacturing systems to address client process demands, building from portfolio of proven modules and platform technology. Invetech is a globally recognized leader in life science automation, and a member of the Fortive (NYSE: FTV) group of companies.